Jan 8, 2025 · Resilience is a biomanufacturing CDMO focused on improving access to complex medicines, with end-to-end solutions for safe and scalable manufacturing. Resilience Partners …

Resilience is home to proven experts in all the fields you might expect – like biopharmaceutical manufacturing, drug research and development, and policy and regulatory science.

Launch your pharmaceutical biomanufacturing career with Resilience, where unconventional innovation is the norm and builders and problem solvers rule.

Innovators in immunotherapy, stem cell therapy, and regenerative medicine will find like-minded champions at Resilience.

RESILIENCE seeks to address today’s challenges while investing in the future of U.S.-led biopharmaceutical innovation. RESILIENCE will offer customized and scalable processes, …

As recombinant protein and monoclonal antibody treatments continue to provide promising pathways for both existing indications and new ones, Resilience has the clinical and …

Whether your focus is on autologous immunotherapies (CAR-T, TCR, TIL), autologous hematopoietic stem cell therapies or allogeneic regenerative medicines (including iPSC-based …

Jan 8, 2025 · Latest news from Resilience. Resilience Partners with Parvus Therapeutics for Development and Manufacturing of PVT401, a Novel Autoimmune Drug Candidate for IBD …

Explore the Resilience network of state-of-the-art biomanufacturing facilities across North America. Resilience Partners with Parvus Therapeutics for Development and Manufacturing of …

Get from clinic to commercialization faster with vaccine development and manufacturing expertise in mRNA, live viruses, and viral vectors from Resilience.